Uploaded image for project: 'eCQM Issue Tracker'
  1. eCQM Issue Tracker
  2. CQM-1741

NCQA will present proposed changes to the IVD Aspirin Measure (CMS164)

XMLWordPrintable

    • Icon: Implementation Problem Implementation Problem
    • Resolution: Done
    • Icon: Minor Minor
    • Measure
    • Implement the proposed changes to the Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic measure during the 2016 Annual Update.
    • Hide
      1. Change measure title to “Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antiplatelet”
      2. Update Denominator to remove “discharge alive” language
      3. Update Numerator and value set name to “Aspirin and Other Antiplatelets”
      4. Add a new exclusion to exclude patients who had documentation of use of anticoagulant medications during the measurement year
      Show
      1. Change measure title to “Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antiplatelet” 2. Update Denominator to remove “discharge alive” language 3. Update Numerator and value set name to “Aspirin and Other Antiplatelets” 4. Add a new exclusion to exclude patients who had documentation of use of anticoagulant medications during the measurement year
    • Hide
      1. Agreed with proposed changes to Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic measure (CMS164): 12/42 (29%)
      2. Disagreed with proposed changes to Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic measure (CMS164): 0/42 (0%)
      3. Did not vote on this issue: 30/42 (71%)
      Show
      1. Agreed with proposed changes to Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic measure (CMS164): 12/42 (29%) 2. Disagreed with proposed changes to Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic measure (CMS164): 0/42 (0%) 3. Did not vote on this issue: 30/42 (71%)

      NCQA would like to discuss an update to the Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic (CMS164) measure that would align the measure with NCQA’s HEDIS physician-level measure and clinical guidelines. The changes include:

      • Update measure title to “Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antiplatelet”

      • Update denominator to “Patients 18 years of age and older with a visit during the measurement period, who were discharged from an inpatient setting with acute myocardial infarction (AMI), coronary artery bypass graft (CABG), or percutaneous coronary interventions (PCI) during the 12 months prior to the measurement year or who had a diagnosis of IVD during the measurement year”

      • Update numerator to “Patients who had documentation of routine use of aspirin or another antiplatelet during the measurement year”

      • Add exclusion: “Patients who had documentation of use of anticoagulant medications during the measurement year”

        1. 6b_NCQA Nov CRP Slides_11 17 15.pptx.pptx
          320 kB

            edave Mathematica EC eCQM Team
            edave Mathematica EC eCQM Team
            Votes:
            1 Vote for this issue
            Watchers:
            3 Start watching this issue

              Created:
              Updated:
              Resolved:
              Solution Posted On: